Aytu BioScience AYTU releases its next round of earnings this Tuesday, October 06. Get the latest predictions in Benzinga's essential guide to the company's Q4 earnings report.
Earnings and Revenue
Sell-side analysts are expecting Aytu BioScience's loss per share to be near $0.03 on sales of $11.24 million. Aytu BioScience's loss in the same period a year ago was $1.3 per share. Quarterly sales came in at $1.72 million. The analyst consensus estimate would represent a 97.69% increase in the company's earnings per share. In comparison to analyst estimates in the past, here's how the company's reported EPS stacks up:
| Quarter | Q3 2020 | Q2 2020 | Q1 2019 | Q4 2019 |
|---|---|---|---|---|
| EPS Estimate | -0.22 | -0.24 | -0.30 | -2.15 |
| EPS Actual | -0.15 | -0.31 | -0.32 | -1.30 |
| Revenue Estimate | 6.40 M | 2.74 M | 2.01 M | 17.04 M |
| Revenue Actual | 8.16 M | 3.17 M | 1.44 M | 1.72 M |
Stock Performance
Over the last 52-week period, shares of Aytu BioScience are up 26.6%.
Don't be surprised to see the stock move on comments made during its conference call. Aytu BioScience is scheduled to hold the call at 16:30:00 ET and can be accessed here: https://www.webcaster4.com/Webcast/Page/2142/37506
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
